Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Lixte Biotechnology Holdings (LIXT) Return on Capital Employed (2016)

Lixte Biotechnology Holdings' Return on Capital Employed history spans 6 years, with the latest figure at 2.5% for Q3 2016.

  • For Q3 2016, Return on Capital Employed fell 9.0% year-over-year to 2.5%; the TTM value through Sep 2016 reached 2.5%, down 9.0%, while the annual FY2015 figure was 9.05%, N/A changed from the prior year.
  • Return on Capital Employed reached 2.5% in Q3 2016 per LIXT's latest filing, down from 1.94% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 60.66% in Q1 2012 to a low of 142.3% in Q1 2014.
  • Average Return on Capital Employed over 5 years is 13.67%, with a median of 7.32% recorded in 2012.
  • Peak YoY movement for Return on Capital Employed: tumbled -13381bps in 2014, then skyrocketed 14000bps in 2015.
  • A 5-year view of Return on Capital Employed shows it stood at 7.32% in 2012, then crashed by -324bps to 31.07% in 2013, then soared by 44bps to 17.36% in 2014, then skyrocketed by 86bps to 2.4% in 2015, then decreased by -4bps to 2.5% in 2016.
  • Per Business Quant, the three most recent readings for LIXT's Return on Capital Employed are 2.5% (Q3 2016), 1.94% (Q2 2016), and 3.41% (Q1 2016).